BMO Capital Markets’s $30 target on PFE

PFE Pfizer

$27.3 → $30 (+10%) by Aug 2027

Buy · maintains · said Aug 18, 2026 · 12-month default horizon

Open: judged on the close on Aug 18, 2027

The article this target came from

BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $30

富途牛牛 · Aug 18, 2026

BMO Capital Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $30

BMO Capital Markets’s track record → Pfizer →

A fact about what BMO Capital Markets published, as reported by 富途牛牛, not a recommendation from Dalsna Finance; BMO Capital Markets is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.